May 09, 2022 / 12:00PM GMT
Operator
Good morning, and thank you for standing by. Welcome to the First Quarter 2022 Adaptimmune Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Juli Miller, Head of Investor Relations. Please go ahead.
Juli P. Miller - Adaptimmune Therapeutics plc - VP of IR
Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2022 financial results and business updates. I would ask you to review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC.
Adrian Rawcliffe, our Chief Executive Officer; and Gavin Wood, our Chief Financial Officer, are here with me for the prepared portion of the call. Other members of our management team will be available for Q&A.
With that, I'll turn the call
Q1 2022 Adaptimmune Therapeutics PLC Earnings Call Transcript
May 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers